Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.
Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores
Javier Camacho
Cervical cancer is a major cause of cancer death in women in developing countries. Thus, novel early markers
and therapeutic targets are urgently needed. Ion channels have gained great interest as tumor markers for different
malignancies including cervical cancer. Actually, some years ago, we suggested Kv10.1 channel as cervical
cancer early marker. Here, we studied the expression of another potassium channel, namely, the calcium-activated
potassium channel KCa1.1 (KCNMA1) in cervical cancer models. Transgenic mice expressing the E7 oncogene of
human papilloma virus and non-transgenic mice were treated with estradiol pellets during three or six months to
induce cervical lesions. Human biopsies from patients with either noncancerous, low- or high-grade intra-epithelium
lesions or cervical cancer were also studied. mRNA and protein expression were studied by real-time RT-PCR and
immunochemistry, respectively. Cervical dysplasia and cervical cancer were observed only in the transgenic mice
treated with estradiol for three and six months, respectively. Estradiol treatment increased KCa1.1 mRNA and protein
expression in both transgenic and non-transgenic mice. However, the highest levels were observed in the transgenic
mice with cervical cancer. Human biopsies form non-cancerous cervix did not display KCa1.1 protein expression.
However, increased KCa1.1 protein expression was observed in the rest of the human biopsies, we observed that the
higher the grade of the lesion, the stronger the KCa1.1 immune staining. These results suggest KCa1.1 channel as
potential early cervical cancer marker.